81 related articles for article (PubMed ID: 17706611)
1. Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells.
Laïos I; Cleeren A; Leclercq G; Nonclercq D; Laurent G; Schlenk M; Wellner A; Gust R
Biochem Pharmacol; 2007 Oct; 74(7):1029-38. PubMed ID: 17706611
[TBL] [Abstract][Full Text] [Related]
2. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Busch S; Gust R
J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
[TBL] [Abstract][Full Text] [Related]
4. Effects of C2-alkylation, N-alkylation, and N,N'-dialkylation on the stability and estrogen receptor interaction of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Schlenk M; Gust R
J Med Chem; 2004 Feb; 47(4):915-27. PubMed ID: 14761193
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
6. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
[TBL] [Abstract][Full Text] [Related]
7. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
[TBL] [Abstract][Full Text] [Related]
8. Cobalt-alkyne complexes with imidazoline ligands as estrogenic carriers: synthesis and pharmacological investigations.
Schlenk M; Ott I; Gust R
J Med Chem; 2008 Nov; 51(22):7318-22. PubMed ID: 18942824
[TBL] [Abstract][Full Text] [Related]
9. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
10. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound estrogen receptor alpha.
Nagayama K; Sasaki S; Matsushita A; Ohba K; Iwaki H; Matsunaga H; Suzuki S; Misawa H; Ishizuka K; Oki Y; Noh JY; Nakamura H
J Endocrinol; 2008 Oct; 199(1):113-25. PubMed ID: 18653622
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition.
Balan KV; Wang Y; Chen SW; Pantazis P; Wyche JH; Han Z
Biochem Pharmacol; 2006 Aug; 72(5):566-72. PubMed ID: 16806088
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
[TBL] [Abstract][Full Text] [Related]
14. ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays.
Leclercq G; Laïos I; Elie-Caille C; Leiber D; Laurent G; Lesniewska E; Tanfin Z; Jacquot Y
J Recept Signal Transduct Res; 2017 Apr; 37(2):149-166. PubMed ID: 27400858
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
[TBL] [Abstract][Full Text] [Related]
19. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
20. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
